Kazuma Nagata

发表

Rebiopsy of non-small cell lung cancer patients with acquired resistance to EGFR-TKI: Comparison between T790M mutation-positive and -negative populations.

K. Kunimasa, T. Ishida, S. Nanjo, 2012 .

Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease.

N. Katakami, D. Fujimoto, M. Kogo, 2015, Anticancer research.

Domiciliary High‐Flow Nasal Cannula Oxygen Therapy for Patients with Stable Hypercapnic Chronic Obstructive Pulmonary Disease. A Multicenter Randomized Crossover Trial

Susumu Sato, T. Kadowaki, T. Kitajima, 2017, Annals of the American Thoracic Society.

Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic

S. Nanjo, N. Katakami, R. Tachikawa, 2011, Respiration.

Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263

J. Fukuoka, R. Tachikawa, D. Fujimoto, 2018, AntiCancer Research.

Clinical Characteristics and Prognosis of Patients With Advanced Non–Small‐cell Lung Cancer Who Are Ineligible for Clinical Trials

T. Morimoto, D. Fujimoto, K. Otsuka, 2018, Clinical lung cancer.

Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study

R. Tachikawa, D. Fujimoto, M. Kogo, 2019, BMC Cancer.

Fatal pemetrexed-induced lung injury in patients with advanced mesothelioma: a report of two cases.

K. Tomii, R. Kaji, Kazuma Nagata, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Efficacy of High-Flow Nasal Cannula Therapy in Acute Hypoxemic Respiratory Failure: Decreased Use of Mechanical Ventilation

T. Morimoto, T. Atsumi, R. Seo, 2015, Respiratory Care.

Efficacy of early intravenous immunoglobulin for eosinophilic granulomatosis with polyangiitis with drastically progressive neuropathy: a synopsis of two cases.

M. Kawamoto, N. Oka, R. Tachikawa, 2013, Internal medicine.

What Is the Impact of Mildly Altered Consciousness on Acute Hypoxemic Respiratory Failure with Non-invasive Ventilation?

T. Morimoto, D. Fujimoto, M. Kogo, 2018, Internal medicine.

Effect of high‐flow nasal cannula oxygen therapy on exercise tolerance in patients with idiopathic pulmonary fibrosis: A randomized crossover trial

R. Tachikawa, T. Morimoto, K. Tomii, 2021, Respirology.

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone

R. Tachikawa, M. Kogo, H. Ikesue, 2020, Frontiers in Pharmacology.

Dissociated Response and Clinical Impact in Patients Treated With Nivolumab Monotherapy

T. Morimoto, R. Tachikawa, S. Hara, 2020 .

The clinical practice of high-flow nasal cannula oxygen therapy in adults: A Japanese cross-sectional multicenter survey.

T. Morimoto, Susumu Sato, R. Tachikawa, 2018, Respiratory investigation.

Predictive performance of PD-L1 tumor proportion score for nivolumab response evaluated using archived specimens in patients with non-small cell lung cancer experiencing a postoperative recurrence

R. Tachikawa, S. Hara, K. Tomii, 2022, Investigational New Drugs.

Reduced Tumour Proportion Scores for Programmed Cell Death Ligand 1 in Stored Paraffin Tissue Sections.

D. Fujimoto, K. Otsuka, K. Tomii, 2018, Anticancer research.

Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes

M. Kaneko, Y. Nakano, T. Hirai, 2022, Respiratory research.

Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial

S. Fuke, T. Ishida, J. Terada, 2022, American journal of respiratory and critical care medicine.

Detection of Herpes Viruses by Multiplex and Real-Time Polymerase Chain Reaction in Bronchoalveolar Lavage Fluid of Patients with Acute Lung Injury or Acute Respiratory Distress Syndrome

R. Seo, R. Tachikawa, H. Hashimoto, 2013, Respiration.

Fulminant fatal bacteremic pneumonia due to Aeromonas hydrophila in a non-immunocompromised woman.

K. Tomii, Y. Imai, Kazuma Nagata, 2011, Internal medicine.

Programmed Cell Death Ligand 1 Expression in Non–Small‐cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case‐control Study

T. Morimoto, D. Fujimoto, K. Otsuka, 2018, Clinical lung cancer.

A pilot trial of nivolumab treatment for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia.

T. Morimoto, D. Fujimoto, K. Otsuka, 2017, Lung cancer.

Association Between Formalin Fixation Time and Programmed Cell Death Ligand 1 Expression in Patients With Non-Small Cell Lung Cancer

J. Fukuoka, R. Tachikawa, D. Fujimoto, 2019, AntiCancer Research.

Predictive Performance of Four Programmed Cell Death Ligand 1 Assay Systems on Nivolumab Response in Previously Treated Patients with Non–Small Cell Lung Cancer

T. Morimoto, J. Fukuoka, D. Fujimoto, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dissociated response and clinical benefit in patients treated with nivolumab monotherapy

T. Morimoto, R. Tachikawa, S. Hara, 2021, Investigational New Drugs.

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

K. Kunimasa, T. Ishida, S. Nanjo, 2013, Cancer.

Role of sedation for agitated patients undergoing noninvasive ventilation: clinical practice in a tertiary referral hospital

M. Mishima, K. Chin, R. Tachikawa, 2015, BMC Pulmonary Medicine.

Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma.

N. Katakami, A. Hata, R. Tachikawa, 2013, Lung cancer.

Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using Nivolumab

T. Morimoto, R. Tachikawa, D. Fujimoto, 2019, Investigational New Drugs.

Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis

N. Katakami, D. Fujimoto, K. Otsuka, 2014, Clinical & Experimental Metastasis.

Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation

S. Fujita, N. Katakami, A. Hata, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

M. Kokubo, D. Fujimoto, K. Otsuka, 2017, Scientific Reports.

T. Morimoto, J. Fukuoka, D. Fujimoto, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Analysis of advanced lung cancer patients diagnosed following emergency admission

T. Morimoto, N. Katakami, D. Fujimoto, 2014, European Respiratory Journal.

The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease

N. Katakami, D. Fujimoto, K. Otsuka, 2014, Cancer Chemotherapy and Pharmacology.

[Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti-CADM-140 antibody].

S. Nanjo, R. Tachikawa, K. Tomii, 2011, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

Diffuse alveolar hemorrhage with predominantly right-sided infiltration resulting from cardiac comorbidities.

K. Otsuka, K. Tomii, Kazuma Nagata, 2015, Internal medicine.

A case of isolated IgG4-related interstitial pneumonia: a new consideration for the cause of idiopathic nonspecific interstitial pneumonia.

Kosuke Tanaka, K. Tomii, Y. Imai, 2012, Chest.

Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health‐related quality of life in patients with interstitial lung disease

R. Tachikawa, K. Otsuka, K. Tomii, 2012, Respirology.